← Back to news
PolicyRSSFriday, April 24, 2026 · Today

Newborn SMA screening widely supported in U.K. survey

WHY IT MATTERS

If newborn SMA screening becomes standard in the U.K., babies diagnosed early could start treatment sooner, potentially preventing severe muscle weakness and improving their long-term quality of life.

A large survey in the U.K. found that most people—including families of babies screened for SMA, people living with SMA, doctors, and the general public—strongly support newborn screening for spinal muscular atrophy. The main reason people liked the idea was that catching SMA early could help babies have better health outcomes. Researchers looked at what factors influenced people's opinions about this type of screening.

Newborn screening (NBS) for spinal muscular atrophy (SMA) is widely supported among families whose babies were screened, SMA families and adults living with the disease, healthcare professionals, and the public, according to a large U.K. survey. The potential for better outcomes for children with SMA was the main reason for this support. Researchers also identified […] The post Newborn SMA screening widely supported in U.K. survey appeared first on SMA News Today .

Read the original at rss
newborn screeningearly detectionsmauk policypatient support

Related conditions

Spinal muscular atrophy associated with central nervous system anomalySpinal muscular atrophy with respiratory distress type 2Spinal muscular atrophy with respiratory distress type 1

Related news

Clinical trialclinicaltrials · March 27, 2026
Trial Now Recruiting: A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France (NCT06875089)
Researchers in France are recruiting 5,000 newborns to test a new way of screening for rare diseases using genome sequen